Additionally, vanadate/VSVΔ51 combination treatment led to an enhancement in T cell recruitment to tumor sites with significantly increased interferon-gamma (IFN-γ) producing CD8+ T cells, particularly in treatment-responsive animals (10). This evidence concerns the gene IFNG and neoplasm.